TipRanks
Advertisement
Advertisement
Imricor Files Q2 2026 10-Q, Confirms Status as Emerging Growth Medical Tech Company
PremiumCompany AnnouncementsImricor Files Q2 2026 10-Q, Confirms Status as Emerging Growth Medical Tech Company
2M ago
Imricor accelerates U.S. MR-guided cardiac launch with Rady Children’s and fresh capital
Premium
Company Announcements
Imricor accelerates U.S. MR-guided cardiac launch with Rady Children’s and fresh capital
2M ago
Imricor Gains Philips Compatibility, Expands iMR Footprint Ahead of ESC Congress
Premium
Company Announcements
Imricor Gains Philips Compatibility, Expands iMR Footprint Ahead of ESC Congress
2M ago
Imricor seeks ASX quotation for over 5 million new CDIs
PremiumCompany AnnouncementsImricor seeks ASX quotation for over 5 million new CDIs
3M ago
Imricor Wins FDA Nod for MR-Guided Pediatric Cardiac Devices in U.S.
Premium
Company Announcements
Imricor Wins FDA Nod for MR-Guided Pediatric Cardiac Devices in U.S.
3M ago
Imricor Registers Shares for Equity Incentive Plan with U.S. SEC
Premium
Company Announcements
Imricor Registers Shares for Equity Incentive Plan with U.S. SEC
3M ago
Imricor Raises Capital via Institutional CDI Placement and Issues Cleansing Notice
PremiumCompany AnnouncementsImricor Raises Capital via Institutional CDI Placement and Issues Cleansing Notice
5M ago
Imricor Seeks ASX Quotation for Over 32 Million New CDIs
Premium
Company Announcements
Imricor Seeks ASX Quotation for Over 32 Million New CDIs
5M ago
Imricor to Release 315,900 Shares from Voluntary Escrow Under ASX Rules
Premium
Company Announcements
Imricor to Release 315,900 Shares from Voluntary Escrow Under ASX Rules
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―